Trial intelligence / Profile preview

Nepafenac Combined With a Lubricant Versus a Lubricant Alone in the Treatment of Epiphora Associated With Lacrimal Punctum Stenosis

NCT07372014Phase 4Active, not recruiting

Sponsor
Instituto de Oftalmología Fundación Conde de Valenciana
Start
Jan 2026
Primary completion
Mar 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of nepafenac in epiphora, Lacrimal punctal stenosis, sponsored by Instituto de Oftalmología Fundación Conde de Valenciana. Started Jan 2026; status: active, not recruiting.

02

Drugs

nepafenac
03

Conditions

epiphoraLacrimal punctal stenosis

Beyond the preview

Go deeper on NCT07372014.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07372014.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call